Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
UnitedHealth
UNH
$353B
| $122M | 0.08% |
240,506
-3,464,264
| -94% | -$1.7B |
|
102
CMS Energy
CMS
$21.4B
| $122M | 0.08% |
2,050,982
-26,873
| -1% | -$1.63M |
|
103
Burlington
BURL
$17.1B
| $120M | 0.08% |
497,931
-22,574
| -4% | -$4.65M |
|
104
Humana
HUM
$46.3B
| $119M | 0.08% |
319,780
+184,556
| +136% | +$62.3M |
|
105
Ferrari
RACE
$73.9B
| $118M | 0.08% |
289,747
+23,139
| +9% | +$9.62M |
|
106
Ero Copper
ERO
$4.05B
| $117M | 0.08% |
5,473,482
+1,475,236
| +37% | +$30.9M |
|
107
Universal Display
OLED
$3.81B
| $116M | 0.07% |
549,569
-186,128
| -25% | -$32.7M |
|
|
PPL
108
PPL Corp
PPL
$25.7B
| $115M | 0.07% |
4,163,935
-53,475
| -1% | -$1.5M |
|
109
Apollo Global Management
APO
$79.7B
| $115M | 0.07% |
973,141
+47,919
| +5% | +$5.44M |
|
110
Centene
CNC
$32B
| $115M | 0.07% |
1,732,335
-210,962
| -11% | -$15.3M |
|
111
Q2 Holdings
QTWO
$4.06B
| $113M | 0.07% |
1,865,843
+13,436
| +0.7% | +$772K |
|
112
Markel Group
MKL
$22.5B
| $110M | 0.07% |
69,944
-6,312
| -8% | -$9.8M |
|
113
Ferguson
FERG
$44.2B
| $109M | 0.07% |
565,245
+33,929
| +6% | +$7.12M |
|
114
Independence Realty Trust
IRT
$3.84B
| $108M | 0.07% |
5,777,663
+1,348,069
| +30% | +$22.5M |
|
115
Tower Semiconductor
TSEM
$23.5B
| $108M | 0.07% |
2,750,953
+100,670
| +4% | +$3.58M |
|
|
PR
116
Permian Resources
PR
$19B
| $108M | 0.07% |
6,680,389
+2,499,132
| +60% | +$41.4M |
|
117
Arcutis Biotherapeutics
ARQT
$2.99B
| $108M | 0.07% |
11,571,694
-604,621
| -5% | -$5.47M |
|
118
Trinity Industries
TRN
$2.33B
| $107M | 0.07% |
3,571,186
+27,661
| +0.8% | +$806K |
|
119
Regeneron Pharmaceuticals
REGN
$81.8B
| $105M | 0.07% |
99,802
+66,281
| +198% | +$64.3M |
|
120
Vaxcyte
PCVX
$8.9B
| $104M | 0.07% |
1,383,131
+126,248
| +10% | +$8.59M |
|
121
RenaissanceRe
RNR
$13.7B
| $104M | 0.07% |
465,615
-31,470
| -6% | -$7.05M |
|
122
argenx
ARGX
$64B
| $102M | 0.07% |
236,438
+3,021
| +1% | +$1.16M |
|
123
NRG Energy
NRG
$23.4B
| $100M | 0.06% |
+1,287,183
| New | +$99.7M |
|
124
monday.com
MNDY
$4.26B
| $99.1M | 0.06% |
411,641
-370,513
| -47% | -$78.1M |
|
125
Becton Dickinson
BDX
$51.6B
| $98M | 0.06% |
419,320
+16,970
| +4% | +$4M |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.